The investigations were carried out on an IDH1 mutation as a prognostic marker of tumor behavior; on MGMT promoter methylation as a predictive response marker to chemotherapy; on Ki-67 level as a reflection of proliferative activity; on p53 protein as an indirect marker of astrocytic neoplasms included in the chain of oncogenesis. This evidence concerns the gene MKI67 and astrocytic tumor.